COVID-19 Update

Our primary concern is the safety of all our study participants and minimising any additional strain on our clinical sites and staff.

The COVID-19 pandemic is affecting people and health services around the world. Our primary concern is the safety of all our study participants and minimising any additional strain on our clinical sites and staff. We are working closely with our clinical sites and partner organisations to find ways of doing this. Please contact the relevant trial team via the trial email address if you have questions about what this means for a specific study.

We are working on developing several studies looking at COVID-19, including the ACTT- EU/UK trial. We hope to open this study in April 2020. It will test drugs to treat people in hospital due the virus. The adaptive design will allow us to add new treatment comparisons as new potential ways to treat the disease are discovered.

Latest News and Updates

MRC CTU at UCL response to COVID-19 pandemic

Our primary concern is the safety of all our study participants and minimising any additional strain on our clinical sites and staff.

26 Mar

New treatment regimen may help patients with extensively drug-resistant TB

This is according to the results of the Nix-TB trial, which were published today in the New England Journal of Medicine.

05 Mar

ICON8 trial shows having chemotherapy every week is no better than having it every three weeks for ovarian cancer

ICON8 was a large international trial looking at whether having smaller doses of chemotherapy more often could help women with epithelial ovarian, fallopian tube, or primary peritoneal cancer. These women are usually tre…

02 Dec

Join our RADICALS and ARTISTIC Twitter Q&A #ProstateRadiotherapy

On Thursday 28 November 2019, we'll be running a Twitter Q&A session about the RADICALS trial and the ARTISTIC meta-analysis - with the hashtag #ProstateRadiotherapy.

21 Nov

Our Research Themes

Cancer

Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types

Infections

Major international clinical trials answering questions of global public health significance

Methodology

Development of methods with direct impact on the design, conduct and analysis of studies

Other Research & Policy

This section will capture projects outside the current QQR themes

Our Latest Tweets

MRC CTU at UCL MRCCTU

Multi-arm, multi-stage trials allow several new treatments to be tested at the same time #clinicaltrials https://t.co/v3MZgVtKBA

Mar 27
MRC CTU at UCL MRCCTU

"Thinking about running a #clinicaltrial with a #platform protocol? Our experiences of running these trials in 3 linked papers might be helpful. 🔓#OpenAccess 🔓 https://t.co/lDHrgDoBJC https://t.co/ayiiK86xz9 https://t.co/g2R5EjfwgJ"

Mar 26
MRC CTU at UCL MRCCTU

#Publication - Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents Read it here for 🔓FREE🔓 https://t.co/8Bb235jt0m

Mar 25